• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

类风湿关节炎患者医疗决策的演变

Evolution of Patient Decision-Making Regarding Medical Treatment of Rheumatoid Arthritis.

作者信息

Mathews Alexandra L, Coleska Adriana, Burns Patricia B, Chung Kevin C

机构信息

University of Michigan, Ann Arbor.

出版信息

Arthritis Care Res (Hoboken). 2016 Mar;68(3):318-24. doi: 10.1002/acr.22688.

DOI:10.1002/acr.22688
PMID:26315611
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5079428/
Abstract

OBJECTIVE

The migration of health care toward a consumer-driven system favors increased patient participation during the treatment decision-making process. Patient involvement in treatment decision discussions has been linked to increased treatment adherence and patient satisfaction. Previous studies have quantified decision-making styles of patients with rheumatoid arthritis (RA); however, none of them have considered the evolution of patient involvement after living with RA for many years. We conducted a qualitative study to determine the decision-making model used by long-term RA patients, and to describe the changes in their involvement over time.

METHODS

Twenty participants were recruited from the ongoing Silicone Arthroplasty in Rheumatoid Arthritis study. Semistructured interviews were conducted and data were analyzed using grounded theory methodology.

RESULTS

Nineteen out of 20 participants recalled using the paternalistic decision-making (PDM) model immediately following their diagnosis. Fourteen of the 19 participants who initially used PDM evolved to shared decision-making (SDM). Participants attributed the change in involvement to the development of a trusting relationship with their physician, as well as to becoming educated about the disease.

CONCLUSION

When initially diagnosed with RA, patients may let their physician decide on the best treatment course. However, over time patients may evolve to exercise a more collaborative role. Physicians should understand that even within SDM, each patient can demonstrate a varied amount of autonomy. It is up to the physician to have a discussion with each patient to determine his or her desired level of involvement.

摘要

目的

医疗保健向消费者驱动型系统的转变有利于在治疗决策过程中增加患者的参与度。患者参与治疗决策讨论与提高治疗依从性和患者满意度有关。先前的研究已经对类风湿关节炎(RA)患者的决策风格进行了量化;然而,这些研究都没有考虑RA患者多年患病后的参与度变化情况。我们进行了一项定性研究,以确定长期RA患者所采用的决策模型,并描述他们随时间推移参与度的变化。

方法

从正在进行的类风湿关节炎硅胶关节成形术研究中招募了20名参与者。进行了半结构化访谈,并使用扎根理论方法对数据进行了分析。

结果

20名参与者中有19人回忆起在确诊后立即采用家长式决策(PDM)模型。最初采用PDM的19名参与者中有14人转变为共同决策(SDM)。参与者将参与度的变化归因于与医生建立了信任关系,以及对疾病有了更多了解。

结论

最初被诊断为RA时,患者可能会让医生决定最佳治疗方案。然而,随着时间的推移,患者可能会逐渐发挥更具协作性的作用。医生应该明白,即使在SDM模式下,每个患者表现出的自主程度也可能不同。医生有责任与每位患者进行讨论,以确定其期望的参与程度。

相似文献

1
Evolution of Patient Decision-Making Regarding Medical Treatment of Rheumatoid Arthritis.类风湿关节炎患者医疗决策的演变
Arthritis Care Res (Hoboken). 2016 Mar;68(3):318-24. doi: 10.1002/acr.22688.
2
Arthritis patients' motives for (not) wanting to be involved in medical decision-making and the factors that hinder or promote patient involvement.关节炎患者(不)愿意参与医疗决策的动机以及阻碍或促进患者参与的因素。
Clin Rheumatol. 2016 May;35(5):1225-35. doi: 10.1007/s10067-014-2820-y. Epub 2014 Nov 14.
3
Patient decision-making related to antirheumatic drugs in rheumatoid arthritis: the importance of patient trust of physician.类风湿关节炎患者在抗风湿药物治疗方面的决策:患者对医生信任的重要性。
J Rheumatol. 2008 Apr;35(4):618-24. Epub 2008 Feb 15.
4
Information and participation in decision-making about treatment: a qualitative study of the perceptions and preferences of patients with rheumatoid arthritis.治疗相关信息及参与决策:一项关于类风湿关节炎患者认知与偏好的定性研究
J Med Ethics. 2008 Nov;34(11):775-9. doi: 10.1136/jme.2007.023705.
5
Practical aspects of therapeutic intervention in rheumatoid arthritis.类风湿关节炎治疗干预的实践要点
J Rheumatol Suppl. 2009 Jun;82:39-41. doi: 10.3899/jrheum.090130.
6
How Rheumatoid Arthritis Patients Make Decisions Regarding Hand Reconstruction: A Qualitative Study from the Silicone Arthroplasty in Rheumatoid Arthritis Project.类风湿关节炎患者如何做出手部重建决策:类风湿关节炎硅胶置换术项目的定性研究
Plast Reconstr Surg. 2016 May;137(5):1507-1514. doi: 10.1097/PRS.0000000000002083.
7
The complexity of the treatment: the decision-making process among women with rheumatoid arthritis.治疗的复杂性:类风湿关节炎女性患者的决策过程。
Qual Health Res. 2011 Feb;21(2):214-22. doi: 10.1177/1049732310381086. Epub 2010 Aug 26.
8
Treat-to-target and shared decision making in rheumatoid arthritis treatment: Is it feasible?达标治疗与类风湿关节炎治疗中的共同决策:是否可行?
Int J Rheum Dis. 2019 Sep;22(9):1706-1713. doi: 10.1111/1756-185X.13664. Epub 2019 Jul 30.
9
Patient-reported outcomes in RA care improve patient communication, decision-making, satisfaction and confidence: qualitative results.类风湿关节炎护理中的患者报告结局可改善患者沟通、决策、满意度和信心:定性结果。
Rheumatology (Oxford). 2020 Jul 1;59(7):1662-1670. doi: 10.1093/rheumatology/kez506.
10
Qualitative Exploration of Triangulated, Shared Decision-Making in Rheumatoid Arthritis.类风湿关节炎中三角式、共享决策的定性探索。
Arthritis Care Res (Hoboken). 2019 Dec;71(12):1576-1582. doi: 10.1002/acr.23801.

引用本文的文献

1
Latent profile analysis for medication adherence in patients with chronic obstructive pulmonary disease.慢性阻塞性肺疾病患者药物依从性的潜在类别分析
BMC Pulm Med. 2025 Jul 30;25(1):363. doi: 10.1186/s12890-025-03859-8.
2
Patient perceptions of an electronic-health-record-based rheumatoid arthritis outcomes dashboard: a mixed-methods study.基于电子病历的类风湿关节炎结果数据仪表盘的患者感知:一项混合方法研究。
BMC Med Inform Decis Mak. 2024 Oct 12;24(1):302. doi: 10.1186/s12911-024-02696-9.
3
Treatment patterns of individualized real-life tapering approaches based on shared decision-making in rheumatoid arthritis.基于共同决策的类风湿关节炎个体化真实世界逐渐减药方案的治疗模式。
Z Rheumatol. 2024 Mar;83(2):142-150. doi: 10.1007/s00393-023-01380-z. Epub 2023 Jun 23.
4
Integrating PROMIS Measures in a Treat-to-Target Approach to Standardize Patient-Centered Treatment of Rheumatoid Arthritis.将 PROMIS 测量指标整合到达标治疗中,以标准化类风湿关节炎的以患者为中心的治疗。
J Rheumatol. 2023 Aug;50(8):1002-1008. doi: 10.3899/jrheum.2022-1176. Epub 2023 May 1.
5
The mechanism of action of paeoniae radix rubra-angelicae sinensis radix drug pair in the treatment of rheumatoid arthritis through PI3K/AKT/NF-κB signaling pathway.赤芍-当归药对通过PI3K/AKT/NF-κB信号通路治疗类风湿关节炎的作用机制
Front Pharmacol. 2023 Mar 13;14:1113810. doi: 10.3389/fphar.2023.1113810. eCollection 2023.
6
Shared decision-making practices and patient values in pharmacist outpatient care for rheumatic disease: A multiple correspondence analysis.风湿性疾病药师门诊护理中的共同决策实践和患者价值观:多对应分析。
J Pharm Pharm Sci. 2023 Jan 20;26:11135. doi: 10.3389/jpps.2023.11135. eCollection 2023.
7
Patients' Characterization of Medication, Emotions, and Incongruent Perceptions around Adherence.患者对药物治疗、情绪及依从性方面不一致认知的描述
J Pers Med. 2021 Sep 29;11(10):975. doi: 10.3390/jpm11100975.
8
Effect of Training on Patient Self-Assessment of Joint Counts in Rheumatoid Arthritis: A Systematic Review.训练对类风湿关节炎患者关节计数自我评估的影响:一项系统评价
ACR Open Rheumatol. 2021 Dec;3(12):860-869. doi: 10.1002/acr2.11344. Epub 2021 Sep 17.
9
Decision Needs and Preferred Strategies for Shared Decision-Making in Rheumatoid Arthritis: Perspectives of Canadian Urban Indigenous Women.类风湿关节炎共同决策的需求和偏好策略:加拿大城市原住民妇女的观点。
Arthritis Care Res (Hoboken). 2022 Aug;74(8):1325-1331. doi: 10.1002/acr.24579. Epub 2022 May 11.
10
Real-world questions and concerns about disease-modifying antirheumatic drugs (DMARDs): a retrospective analysis of questions to a medicine call center.关于改善病情抗风湿药(DMARDs)的现实世界问题与担忧:对医学呼叫中心问题的回顾性分析
BMC Rheumatol. 2020 Jun 16;4:27. doi: 10.1186/s41927-020-00126-7. eCollection 2020.

本文引用的文献

1
Arthritis patients' motives for (not) wanting to be involved in medical decision-making and the factors that hinder or promote patient involvement.关节炎患者(不)愿意参与医疗决策的动机以及阻碍或促进患者参与的因素。
Clin Rheumatol. 2016 May;35(5):1225-35. doi: 10.1007/s10067-014-2820-y. Epub 2014 Nov 14.
2
Patient participation in decisions about disease modifying anti-rheumatic drugs: a cross-sectional survey.患者参与改善病情抗风湿药物治疗决策的横断面调查。
BMC Musculoskelet Disord. 2014 Oct 4;15:333. doi: 10.1186/1471-2474-15-333.
3
Patient expectations and long-term outcomes in rheumatoid arthritis patients: results from the SARA (Silicone Arthroplasty in Rheumatoid Arthritis) study.类风湿关节炎患者的期望与长期预后:类风湿关节炎硅胶关节成形术(SARA)研究结果
Clin Rheumatol. 2015 Apr;34(4):641-51. doi: 10.1007/s10067-014-2775-z. Epub 2014 Sep 30.
4
Decision tool to improve the quality of care in rheumatoid arthritis.改善类风湿关节炎护理质量的决策工具。
Arthritis Care Res (Hoboken). 2012 Jul;64(7):977-85. doi: 10.1002/acr.21657.
5
Compliance with treatment of rheumatoid arthritis.类风湿关节炎的治疗依从性。
Rheumatol Int. 2012 Oct;32(10):3131-5. doi: 10.1007/s00296-011-2162-x. Epub 2011 Sep 24.
6
The complexity of the treatment: the decision-making process among women with rheumatoid arthritis.治疗的复杂性:类风湿关节炎女性患者的决策过程。
Qual Health Res. 2011 Feb;21(2):214-22. doi: 10.1177/1049732310381086. Epub 2010 Aug 26.
7
Decision aids for people facing health treatment or screening decisions.为面临医疗治疗或筛查决策的人群提供的决策辅助工具。
Cochrane Database Syst Rev. 2009 Jul 8(3):CD001431. doi: 10.1002/14651858.CD001431.pub2.
8
Do people want to be autonomous patients? Preferred roles in treatment decision-making in several patient populations.人们希望成为自主的患者吗?几个患者群体在治疗决策中的偏好角色。
Health Expect. 2007 Sep;10(3):248-58. doi: 10.1111/j.1369-7625.2007.00441.x.
9
Delay in presentation to primary care physicians is the main reason why patients with rheumatoid arthritis are seen late by rheumatologists.延迟向初级保健医生就诊是类风湿性关节炎患者被风湿病专家诊治较晚的主要原因。
Rheumatology (Oxford). 2007 Sep;46(9):1438-40. doi: 10.1093/rheumatology/kem130. Epub 2007 Jun 19.
10
Adherence to medication.药物依从性
N Engl J Med. 2005 Aug 4;353(5):487-97. doi: 10.1056/NEJMra050100.